Over half a decade, Abbott Laboratories managed to grow its earnings per share at 12% a year. The EPS growth is more ...
They’re at the center of a legal battle with the makers of specialized formulas for preterm infants — north suburban-based ...
Democratic Sen. Ron Wyden, D-Ore., is questioning Abbott Laboratories' business practices after the shutdown of one of the company's plants exacerbated the baby formula shortage in the U.S. While ...
Marie Thibault, an analyst from BTIG, reiterated the Buy rating on Abbott Laboratories (ABT – Research Report). The associated price ...
Abbott Laboratories (NYSE:ABT), together with its subsidiaries, discovers, develops, manufactures and sells health care ...
As Abbott Laboratories prepares to build a plant and bring 450 jobs to Bowling Green, company officials asked for permission to have more fencing and less greenery than required by city zoning. On ...
Unfortunately for shareholders, while the Abbott Laboratories (NYSE ... return has matched the performance of the underlying business. To paraphrase Benjamin Graham: Over the short term the ...